[Federal Register Volume 80, Number 81 (Tuesday, April 28, 2015)]
[Notices]
[Pages 23528-23529]
[FR Doc No: 2015-09744]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. AD15-10-000]

Notice of Intent To Update the Guidelines for Reporting on
Cultural Resources Investigations for Pipeline Projects and Request for
Comments

    The staff of the Office of Energy Projects (OEP) is in the process
of reviewing its Guidelines for Reporting on Cultural Resources
Investigations for Pipeline Projects (Guidelines), dated December 2002,
to determine if updates or improvements are appropriate. The staff is
asking for public input and suggestions for modifications to the
Guidelines from federal and state agencies, Native American tribes,
environmental consultants, inspectors, natural gas industry,
construction

contractors, and other interested parties with special expertise with
respect to historic and cultural resources commonly associated with
pipeline projects. Please note that this comment period will close on
July 20, 2015.
    The Guidelines are referred to at 18 Code of Federal Regulations
(CFR) 380.12(f). Full text of the current version of the Guidelines can
be viewed on the Federal Energy Regulatory Commission (FERC or
Commission) Web site at http://www.ferc.gov/industries/gas/enviro/guidelines.asp.
    Based on the input received in response to this notice, OEP staff
anticipates issuing draft changes to the Guidelines by fall 2015, and
will make them available for public comment. We will then consider all
timely comments on the drafts before issuing the final version.
    Interested parties can help us determine the appropriate updates
and improvements to make by providing us comments or suggestions that
focus on the specific sections requiring clarification, updates to
reflect current laws and regulations, or improved measures to avoid or
minimize impacts on historic or cultural resources. The more specific
your comments, the more useful they will be. A detailed explanation of
your submissions and/or any references of scientific studies associated
with your comments would greatly help us with this process.
    For your convenience, there are three methods which you can use to
submit your comments to the Commission. In all instances please
reference the docket number (AD15-10-000) with your submission. The
Commission encourages electronic filing of comments and has expert
staff available to assist you at<PHONE_NUMBER> or<EMAIL_ADDRESS>    (1) You can file your comments electronically using the eComment
feature on the Commission's Web site (www.ferc.gov) under the link to
Documents and Filings. This is an easy method for interested persons to
submit brief, text-only comments;
    (2) You can file your comments electronically using the eFiling
feature on the Commission's Web site (www.ferc.gov) under the link to
Documents and Filings. With eFiling, you can provide comments in a
variety of formats by attaching them as a file with your submission.
New eFiling users must first create an account by clicking on
``eRegister.'' You must select the type of filing you are making,
select ``Comment on a Filing''; or
    (3) You can file a paper copy of your comments by mailing them to
the following address: Kimberly D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street NE., Room 1A, Washington, DC
20426.
    All of the information related to the proposed updates to the
Guidelines and submitted comments can be found on the FERC Web site
(www.ferc.gov) using the eLibrary link. Click on the eLibrary link,
click on ``General Search'' and enter the docket number, excluding the
last three digits in the Docket Number field (i.e., AD15-10). Be sure
you have selected an appropriate date range. For assistance, please
contact FERC Online Support at<EMAIL_ADDRESS>or toll free
at<PHONE_NUMBER>, or for TTY, contact<PHONE_NUMBER>. The eLibrary
link also provides access to the texts of formal documents issued by
the Commission, such as orders, notices, and rulemakings.
    In addition, the Commission now offers a free service called
eSubscription which allows you to keep track of all formal issuances
and submittals in specific dockets. This can reduce the amount of time
you spend researching proceedings by automatically providing you with
notification of these filings, document summaries, and direct links to
the documents. Go to www.ferc.gov/docs-filing/esubscription.asp.

     Dated: April 21, 2015.
Kimberly D. Bose,
Secretary.
[FR Doc. 2015-09744 Filed 4-27-15; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: October 5, 2010 (Volume 75, Number 192)]
[Notices]
[Page 61560-61561]
[DOCID:fr05oc10-161]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

Petition for Waiver of Compliance

    In accordance with part 211 of Title 49 Code of Federal Regulations
(CFR), notice is hereby given that the Federal Railroad Administration
(FRA) has received a request for a waiver of compliance from certain
requirements of its safety standards. The individual petition is
described below, including the party seeking relief, the regulatory
provisions involved, the nature of the relief being requested, and the
petitioner's arguments in favor of relief.

Hoosier Valley Railroad Museum, Inc.

[Waiver Petition Docket Number FRA-2010-0138)]

    The Hoosier Valley Railroad Museum, Inc. (HVRM) seeks a waiver of
compliance from certain provisions of the Railroad Freight Car Safety
Standards, 49 CFR 215.303, which requires stenciling of restricted
cars. HVRM owns four cabooses (Car Numbers: B&LE 1989, EL C345, GTW
75072, and EJ&E 184) and a flat car (Car Number: NKP 1946) that are
older than 50 years from their date of original construction, and are
restricted by the provision of 49 CFR 215.203(a). HVRM is concurrently
seeking special approval to continue to use these cars under proceeding
according to 49 CFR 215.203(b).
    To support its petition to seek relief from the stenciling
requirement, HVRM states that it is an Indiana Corporation and a
501(c)(3) non-profit organization whose mission is to preserve railroad
history in northwest Indiana. HRVM exercises complete control in the
maintenance of these freight cars. Each car subject to this petition is
lettered and painted according to its historic appearance at the time
of its construction. Stenciling these cars in order to meet the letter
of Sec.  215.303 would violate the historic impression that these cars
are maintained to preserve.
    The cars subject to this waiver are limited in their service by
speed, lading and territory. Specifically, their operation will be
confined to the Chesapeake & Indiana Railroad over tracks owned by the
Town of North Judson, Indiana, at limited track speed, with light
tonnage (if any), in accordance with CFR Part 215. These cars will
never be subject to regular railroad interchange operations at the
hands of a strange crew unfamiliar with their characteristics.
    HVRM further stated that its restricted cars will always be
operated in context that ensures that each car and its sensibilities
are readily accessible and known both to HVRM as operator, and to FRA
as railroad safety regulation enforcer. HVRM believes that the greatest
inconvenience to the FRA's inspectors would be the identification of
obvious defects as to type and obsolete parts on the cars without the
benefit of supporting paperwork in hand. This inconvenience could be
easily remedied by HVRM making available to the FRA's

inspectors at HVRM's business office all of Sec.  215.203 paperwork
concerning each car subject to this petition.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested party
desires an opportunity for oral comment, they should notify FRA, in
writing, before the end of the comment period and specify the basis for
their request.
    All communications concerning these proceedings should identify the
appropriate docket number (e.g., Waiver Petition Docket Number FRA-
2010-0138) and may be submitted by any of the following methods:
     Web site: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue, SE., W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue, SE., Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
    Communications received within 45 days of the date of this notice
will be considered by FRA before final action is taken. Comments
received after that date will be considered as far as practicable. All
written communications concerning these proceedings are available for
examination during regular business hours (9 a.m.-5 p.m.) at the above
facility. All documents in the public docket are also available for
inspection and copying on the Internet at the docket facility's Web
site at http://www.regulations.gov.
    Anyone is able to search the electronic form of any written
communications and comments received into any of our dockets by the
name of the individual submitting the document (or signing the
document, if submitted on behalf of an association, business, labor
union, etc.). You may review DOT's complete Privacy Act Statement in
the Federal Register published on April 11, 2000 (65 FR 19477) or at
http://www.dot.gov/privacy.html.

    Issued in Washington, DC, on September 28, 2010.
Robert C. Lauby,
Deputy Associate Administrator for Regulatory and Legislative
Operations.
[FR Doc. 2010-24999 Filed 10-4-10; 8:45 am]
BILLING CODE 4910-06-P


[Federal Register Volume 79, Number 225 (Friday, November 21, 2014)]
[Notices]
[Pages 69453-69454]
[FR Doc No: 2014-27554]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 14628-000]

Minnesota Leased Housing Associates IV, Limited Partnership;
Notice of Scoping Meeting, Initial Information Meeting, and Soliciting
Scoping Comments for an Applicant Prepared Environmental Assessment
Using the Alternative Licensing Process

    a. Type of Filing: Notice of Intent to File License Application and
Pre-Application Document for an Original License.
    b. Project No.: 14628-000.
    c. Applicant: Minnesota Leased Housing Associates IV, Limited
Partnership (Minnesota Housing Associates).
    d. Name of Project: A-Mill Artists Loft Hydroelectric Project (A-
Mill Project).
    e. Location: On the Mississippi River, in the city of Minneapolis,
Hennepin County, Minnesota.
    f. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791(a)-825(r).
    g. Applicant Contact: Owen Metz, 2905 Northwest Blvd., Suite 150,
Plymouth, MN 55441;<PHONE_NUMBER>; email<EMAIL_ADDRESS>    h. FERC Contact: Janet Hutzel at<PHONE_NUMBER>; or email at
<EMAIL_ADDRESS>    i. Deadline for filing scoping comments: January 3, 2015.
    The Commission strongly encourages electronic filing. Please file
comments using the Commission's eFiling system at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit brief comments up to
6,000 characters, without prior registration, using the eComment system
at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your
name and contact information at the end of your comments. For
assistance, please contact FERC Online Support at
<EMAIL_ADDRESS>(866) 208-3676 (toll free), or (202) 502-
8659 (TTY). In lieu of electronic filing, please send a paper copy to:
Secretary, Federal Energy Regulatory Commission, 888 First Street NE.,
Washington, DC 20426. The first page of any filing should include
docket number P-14628-000.
    j. The proposed project would consist of: (1) Removal of the
existing concrete bulkhead blocking the existing intake structure and
installation of a new trash rack at the intake; (2) an existing
headrace tunnel that would be rehabilitated and sleeved with a new
horizontal 600-foot-long, 5-foot-diameter steel penstock; (3) a new
vertical 50-foot-long, 5-foot diameter steel pipe installed in an
existing downstream drop-shaft; (4) a new sluice gate; (5) a new 650-
kilowatt turbine/generator set and related control system; (6) a new
outlet structure consisting of a 4-foot-high by 6-foot-wide concrete
box culvert installed on the invert of the existing downstream
tailrace; and (7) appurtenant facilities.
    k. Scoping Process: Minnesota Housing Associates intends to utilize
the Federal Energy Regulatory Commission's (Commission) alternative
licensing process (ALP). Under the ALP, Minnesota Housing Associates
will prepare an Applicant Prepared Environmental Assessment (APEA) and
license application for the A-Mill Project.
    Minnesota Housing Associates expects to file with the Commission,
the APEA and the license application for the A-Mill Project by January
2015. Although the Commission's intent is to prepare an environmental
assessment (EA), there is the possibility that an Environmental Impact
Statement (EIS) will be required. Nevertheless, this meeting will
satisfy the NEPA scoping requirements, irrespective of whether an EA or
EIS is issued by the Commission.
    The purpose of this notice is to inform you of the opportunity to
participate in the upcoming scoping meetings and environmental site
review identified

below, and to solicit your scoping comments.

Scoping Meetings, Initial Information Meeting (also known as a Joint
Meeting), and Environmental Site Review \1\
---------------------------------------------------------------------------

    \1\ With this notice, 18 CFR 4.38(b)(3)(ii), the requirement to
hold an initial information meeting, also known as a joint meeting,
no earlier than 30 days and no later than 60 days after the
Alternative Licensing Process is approved, is waived. Holding the
initial information meeting outside the required timeframe will
result in greater participation from the licensing participants.
---------------------------------------------------------------------------

    Minnesota Housing Associates will hold two scoping meetings, one in
the daytime and one in the evening, to help us identify the scope of
issues to be addressed in the APEA. The initial information meeting
will be held at the same time as the daytime scoping meeting.
    The daytime scoping meeting will focus on resource agency concerns,
while the evening scoping meeting is primarily for public input. All
interested individuals, organizations, and agencies are invited to
attend one or both of the meetings, and to assist the staff in
identifying the environmental issues that should be analyzed in the
APEA. The times and locations of these meetings and environmental site
review are as follows:

Daytime Meeting

Thursday, December 4, 2014 at 12 p.m. (CST), 1000 LaSalle Avenue, Room
202 of the Terrence Murphy Hall, Minneapolis, MN 55403.

Evening Meeting

    Thursday, December 4, 2014 at 5 p.m. (CST), 1000 LaSalle Avenue,
Room 202 of the Terrence Murphy Hall, Minneapolis, MN 55403.

Environmental Site Review

Thursday, December 4, 2014 at 2 p.m. (CST), Xcel Energy Water Power
Park, 206 Main Street SE., Minneapolis, MN 55414.
    Please notify Neal Route at<PHONE_NUMBER>, or email:
<EMAIL_ADDRESS>if you plan to attend the environmental site
review.
    To help focus discussions, Minnesota Housing Associates will mail
the Scoping Document 1 (SD1), outlining the subject areas to be
addressed in the APEA, to the parties on the mailing and distribution
list. Copies of the SD1 also will be available at the scoping meetings.
Minnesota Housing Associates will file SD1 with the Commission and the
document will be available for review at the Commission in the Public
Reference Room or may be viewed on the Commission's Web site at http://www.ferc.gov using the ``eLibrary'' link. Enter the docket number
excluding the last three digits (P-14628) in the docket number field to
access the document.
    You may also register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filings and issuances
related to this or other pending projects. For assistance, contact
<EMAIL_ADDRESS>    Based on all written comments received, a Scoping Document 2 (SD2)
may be issued. SD2 will include a revised list of issues, based on the
scoping sessions.

Meeting Objectives

    At the scoping meetings, Minnesota Housing Associates will: (1)
Summarize the environmental issues tentatively identified for analysis
in the APEA; (2) solicit from the meeting participants all available
information, especially quantifiable data, on the resources at issue;
(3) encourage statements from experts and the public on issues that
should be analyzed in the APEA, including viewpoints in opposition to,
or in support of, Minnesota Housing Associates' preliminary views; (4)
determine the resource issues to be addressed in the APEA; and (5)
identify those issues that require a detailed analysis, as well as
those issues that do not require a detailed analysis.

Meeting Procedures

    The meetings will be recorded by a stenographer and will become
part of the formal record of the Commission proceeding on the project.

    Dated: November 14, 2014.
Kimberly D. Bose,
Secretary.
[FR Doc. 2014-27554 Filed 11-20-14; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 176 (Tuesday, September 11, 2018)]
[Notices]
[Pages 45934-45936]
[FR Doc No: 2018-19669]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-3223]

Joint Meeting of the Gastrointestinal Drugs Advisory Committee
and the Drug Safety and Risk Management Advisory Committee; Notice of
Meeting; Establishment of a Public Docket; Request for Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; establishment of a public docket; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming
public advisory committee meeting of the Gastrointestinal Drugs
Advisory Committee and the Drug Safety and Risk Management Advisory

Committee. The general function of the committees is to provide advice
and recommendations to FDA on regulatory issues. The meeting will be
open to the public. FDA is establishing a docket for public comment on
this document.

DATES: The meeting will be held on October 17, 2018, from 8 a.m. to 5
p.m.

ADDRESSES: Bethesda Marriott, 5151 Pooks Hill Rd., the Grand Ballroom,
Bethesda, MD 20814. The conference center's telephone number is 301-
897-9400. Answers to commonly asked questions including information
regarding special accommodations due to a disability, visitor parking,
and transportation may be accessed at: https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm. Information
about the Bethesda Marriott can be accessed at: https://www.marriott.com/hotels/travel/wasbt-bethesda-marriott/.
    FDA is establishing a docket for public comment on this meeting.
The docket number is FDA-2018-N-3223. The docket will close on October
16, 2018. Submit either electronic or written comments on this public
meeting by October 16, 2018. Please note that late, untimely filed
comments will not be considered. Electronic comments must be submitted
on or before October 16, 2018. The https://www.regulations.gov
electronic filing system will accept comments until midnight Eastern
Time at the end of October 16, 2018. Comments received by mail/hand
delivery/courier (for written/paper submissions) will be considered
timely if they are postmarked or the delivery service acceptance
receipt is on or before that date.
    Comments received on or before October 9, 2018, will be provided to
the committees. Comments received after that date will be taken into
consideration by FDA.
    You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-N-3223 for ``Joint Meeting of the Gastrointestinal Drugs
Advisory Committee and the Drug Safety and Risk Management Advisory
Committee; Notice of Meeting; Establishment of a Public Docket; Request
for Comments.'' Received comments, those filed in a timely manner (see
the ADDRESSES section), will be placed in the docket and, except for
those submitted as ``Confidential Submissions,'' publicly viewable at
https://www.regulations.gov or at the Dockets Management Staff between
9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' FDA will review
this copy, including the claimed confidential information, in its
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify the information as ``confidential.'' Any
information marked as ``confidential'' will not be disclosed except in
accordance with 21 CFR 10.20 and other applicable disclosure law. For
more information about FDA's posting of comments to public dockets, see
80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Jay R. Fajiculay, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, Fax:<PHONE_NUMBER>, email: [email protected], or FDA Advisory
Committee Information Line, 1-800-741-8138<PHONE_NUMBER> in the
Washington, DC area). A notice in the Federal Register about last
minute modifications that impact a previously announced advisory
committee meeting cannot always be published quickly enough to provide
timely notice. Therefore, you should always check the FDA's website at
https://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to
the appropriate advisory committee meeting link, or call the advisory
committee information line to learn about possible modifications before
coming to the meeting.

SUPPLEMENTARY INFORMATION:
    Agenda: The committees will discuss supplemental new drug
application (sNDA) 021200, supplement 015, for ZELNORM (tegaserod
maleate) tablets for oral administration, submitted by Sloan Pharma
S.[agrave].r.l, Bertrange, Cham Branch, proposed for the treatment of
women with irritable bowel syndrome with constipation who do not have a
history of cardiovascular ischemic disease, such as myocardial
infarction, stroke, transient ischemic attack, or angina, and who do
not have more than one risk factor for cardiovascular disease.

    FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its website prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's website after the meeting. Background material is
available at https://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee meeting
link.
    Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committees.
All electronic and written submissions submitted to the Docket (see the
ADDRESSES section) on or before October 9, 2018, will be provided to
the committees. Oral presentations from the public will be scheduled
between approximately 1 p.m. and 2 p.m. Those individuals interested in
making formal oral presentations should notify the contact person and
submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation on or before October 1, 2018. Time allotted for
each presentation may be limited. If the number of registrants
requesting to speak is greater than can be reasonably accommodated
during the scheduled open public hearing session, FDA may conduct a
lottery to determine the speakers for the scheduled open public hearing
session. The contact person will notify interested persons regarding
their request to speak by October 2, 2018.
    Persons attending FDA's advisory committee meetings are advised
that FDA is not responsible for providing access to electrical outlets.
    For press inquiries, please contact the Office of Media Affairs at
[email protected] or<PHONE_NUMBER>.
    FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
disabilities. If you require accommodations due to a disability, please
contact Jay Fajiculay (see FOR FURTHER INFORMATION CONTACT) at least 7
days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our website at https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).

    Dated: September 4, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-19669 Filed 9-10-18; 8:45 am]
 BILLING CODE 4164-01-P